# Heron Therapeutics, Inc.: Form 8-K, filed Jan 9, 2026

- Company: [Heron Therapeutics, Inc.](/companies/hrtx.md) (CIK 818033)
- Form: 8-K
- Filed: 2026-01-09
- Accepted by EDGAR: Jan 9, 2026, 13:08 ET
- Period: 2026-01-09
- Accession: 0001193125-26-008631
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/818033/000119312526008631/hrtx-20260109.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/818033/000119312526008631/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/818033/000119312526008631/hrtx-20260109.htm

Filed Jan 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-008631. Last ingested by Listed: Nov 10, 2026, 18:29 ET. No prices; not investment advice.
